List view / Grid view
29 July 2015 | By Victoria White
Eisai has received a Breakthrough Therapy designation for Lenvima for the potential indication of advanced and/or metastatic renal cell carcinoma...
29 July 2015 | By Victoria White
A study has found firms "underinvest" in long-term research to develop new cancer drugs due to the greater time and cost required to conduct such research...
29 July 2015 | By Victoria White
Mereo BioPharmahas successfully raised $119m and simultaneously acquired a portfolio of three innovative clinical-stage development programmes from Novartis...
29 July 2015 | By Victoria White
The UK National Institute for Health and Care Excellence has published draft guidance recommending three different treatment options for hepatitis C...
29 July 2015 | By Victoria White
TxCell and MaSTherCell have signed a Memorandum of Understanding for the manufacturing by MaSTherCell of clinical batches of TxCell’s Ovasave...
29 July 2015 | By Victoria White
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin...
28 July 2015 | By Victoria White
Teva has successfully filed a MAA with the EMA for reslizumab -a humanised anti-IL-5 monoclonal antibody for the treatment of inadequately controlled asthma...
28 July 2015 | By Victoria White
Atezolizumab is poised to become a major bladder cancer therapy in the race for FDA approval, following its promising performance in recent Phase II trials...
28 July 2015 | By Victoria White
Four public health organisations have warned of acute shortages of meningitis C-containing vaccine as the risk of a meningitis C outbreak in Africa grows...
28 July 2015 | By Victoria White
The latest figures from Public Health England show hospital admissions from hepatitis C-related end-stage liver disease and liver cancer continue to rise...
28 July 2015 | By Victoria White
New data analyses provide a comprehensive picture of the potential public health impact of vaccinating pre-adolescents and adults against dengue...
28 July 2015 | By Victoria White
Boehringer Ingelheim has entered an exclusive and collaboration agreement for the development and global commercialisation rights of HM61713...
28 July 2015 | By Victoria White
Following yesterday’s news that Teva is to acquire Allergan’s global generics business, Teva has withdrawn its cash and stock proposal to acquire Mylan...
28 July 2015 | By Victoria White
ESCMID is imploring global healthcare professionals and bodies to take a more active role in the growing problem of fungal resistance...
28 July 2015 | By Shimadzu Europa GmbH
RF-6000 spectrofluorophotometer provides comprehensive range of applications. Superior analysis capabilities meet enhanced ease-of-use....
